• DOI:10.1056/NEJMOA065464
Corpus ID: 2031300

A comparison of allografting with autografting for newly diagnosed myeloma.

@article{Bruno2007ACO,
  title={A comparison of allografting with autografting for newly diagnosed myeloma.},
  author={B. Bruno and M. Rotta and F. Patriarca and N. Mordini and B. Allione and F. Carnevale-Schianca and L. Giaccone and R. Sorasio and P. Omede' and I. Baldi and S. Bringhen and M. Massaia and M. Aglietta and A. Levis and A. Gallamini and R. Fanin and A. Palumbo and R. Storb and G. Ciccone and M. Boccadoro},
  journal={The New England journal of medicine},
  year={2007},
  volume={356 11},
  pages={
          1110-20
        }
}

B. Bruno, M. Rotta, +17 authors M. Boccadoro

Published 2007

Medicine

The New England journal of medicine

BACKGROUND In this trial of the treatment of newly diagnosed multiple myeloma, we compared a protocol that entailed a hematopoietic stem-cell autograft followed by an allograft from an HLA-identical sibling with a protocol of tandem autografts. METHODS We enrolled 162 consecutive patients with newly diagnosed myeloma who were 65 years of age or younger and who had at least one sibling. All patients were initially treated with vincristine, doxorubicin, and dexamethasone, followed by melphalan… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite

Launch Research Feed